COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1257: Articles 12561-12570  | Next

Detection of SARS-CoV-2 in the community by nucleic acid amplification testing of saliva
Fronza, F., Groff, N., Martinelli, A., Passerini, B. Z., Rensi, N., Cortelletti, I., Vivori, N., Adami, V., Helander, A., Bridi, S., Pancher, M., Greco, V., Garritano, S. I., Piffer, E., Stefani, L., De Sanctis, V., Bertorelli, R., Pancheri, S., Collini, L., Quattrone, A., Capobianchi, M. R., Icardi, G., Poli, G., Caciagli, P., Ferro, A., Pizzato, M.
10.1101/2021.09.15.21263644 — Posted: 2021-09-20
Distributed Counterfactual Modeling Approach for Investigating Hospital-Associated Racial Disparities in COVID-19 Mortality
Edmondson, M. J., Luo, C., Islam, N., Asch, D., Bian, J. J., Chen, Y.
10.1101/2021.09.14.21263596 — Posted: 2021-09-20
Sex differences in cardio-pulmonary pathology of SARS-CoV2 infected and Trypanosoma cruzi co-infected mice
Dhanyalayam, D., Lizardo, K., Oswal, N., Thangavel, H., Dolgov, E., Perlin, D. S., Nagajyothi, J. F.
10.1101/2021.09.18.460895 — Posted: 2021-09-18
Copper(II) Gluconate Boosts the Anti-SARS-CoV-2 Effect of Disulfiram in Vitro
Xu, L., Xu, W., Zhao, S., Zhao, S., Lu, L., Lin, B.-L.
10.1101/2021.09.17.460613 — Posted: 2021-09-18 Discussion: Onsite
Genetically diverse mouse models of SARS-CoV-2 infection model clinical variation and cytokine responses in COVID-19
Robertson, S., Bedard, O., McNally, K., Lewis, M., Clancy, C., Shaia, C., Broeckel, R., Chiramel, A., Sturdevant, G., Forte, E., Preuss, C., Baker, C., Sturdevant, D., Martens, C., Holland, S., Rosenthal, N., Best, S.
10.1101/2021.09.17.460664 — Posted: 2021-09-18
3D virtual Histopathology of Cardiac Tissue from Covid-19 Patients based on Phase-Contrast X-ray Tomography
Reichardt, M., Moller Jensen, P., Andersen Dahl, V., Bjorholm Dahl, A., Ackermann, M., Shah, H., Länger, F., Werlein, C., Kuehnel, M. P., Jonigk, D., Salditt, T.
10.1101/2021.09.16.460594 — Posted: 2021-09-18
Altered fibrin clot structure contributes to thrombosis risk in severe COVID-19
Wygrecka, M., Birnhuber, A., Seeliger, B., Michalick, L., Pak, O., Schultz, A.-S., Schramm, F., Zacharias, M., Gorkiewicz, G., David, S., Welte, T., Schmidt, J. J., Weissmann, N., Schermuly, R. T., Barreto, G., Schäfer, L., Markart, P., Brack, M. C., Hippenstiel, S., Kurth, F., Sander, L. E., Witzenrath, M., Kuebler, W. M., Kwapiszewska, G., Preissner, K. T.
10.1101/2021.09.17.460777 — Posted: 2021-09-18
ZRC3308 monoclonal antibody cocktail shows protective efficacy in Syrian hamsters against SARS-CoV-2 infection
Yadav, P., Mendiratta, S. K., Mohandas, S., Singh, A. K., Abraham, P., Shete, A., Bandhyopadhyay, S., Kumar, S., Parikh, A., Kalita, P., Sharma, V., Pandya, H., Patel, C. G., Patel, M., Soni, S., Giri, S., Jain, M.
10.1101/2021.09.16.460724 — Posted: 2021-09-17
The nuts and bolts of SARS-CoV-2 Spike Receptor Binding Domain heterologous expression
Maffei, M., Montemiglio, L. C., Vitagliano, G., Fedele, L., Sellathurai, S., Bucci, F., Compagnone, M., Chiarini, V., Exertier, C., Muzi, A., Roscilli, G., Vallone, B., Marra, E.
10.1101/2021.09.17.460782 — Posted: 2021-09-17
A novel hamster model of SARS-CoV-2 respiratory infection using a pseudotyped virus
Yamada, H., Sasaki, S., Tani, H., Somekawa, M., Kawasuji, H., Saga, Y., Yoshida, Y., Yamamoto, Y., Hayakawa, Y., Morinaga, Y.
10.1101/2021.09.17.460745 — Posted: 2021-09-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).